glp 1 roche obesity drug shows 22.5% weight loss as it seeks to catch up with Lilly, Novo Roche's GLP1/GIP drug sees 22.5%

Oral administration of Spirulina was demonstrated to decrease blood pressure and lipid concentration, particularly low density lipoprotein cholesterol (LDL-C) and triacylglycerols

Lee YK, Romera-Castillo C, Hong S, Hur J (2020) Characteristics of microplastic polymer-derived dissolved organic matter and its potential as a disinfection byproduct precursor

If your liver can't package and export fat efficiently, weight loss stalls even when you're eating below maintenance

Considering dose splitting Some practitioners and patients have explored splitting the weekly dose into two smaller injections given 3 to 4 days apart

Bydureon BCise is a once-weekly injection